Condition
Heart; Complications, Valve, Prosthesis
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02304276Not ApplicableCompletedPrimary
18F-Fluoride Assessment of Aortic Bioprosthesis Durability and Outcome
NCT01802619Phase 1Completed
Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.
NCT02240927Not ApplicableUnknown
Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves
Showing all 3 trials